Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2059892851', 'doi': 'https://doi.org/10.1016/j.juro.2014.02.285', 'title': 'MP24-04 CO-TARGETING CLUSTERIN AND THE ANDROGEN RECEPTOR WITH OGX-011 AND AN AR ANTISENSE SYNERGISTICALLY ENHANCES ACTIVITY OF ENZALUTAMIDE-RESISTANT PROSTATE CANCER', 'display_name': 'MP24-04 CO-TARGETING CLUSTERIN AND THE ANDROGEN RECEPTOR WITH OGX-011 AND AN AR ANTISENSE SYNERGISTICALLY ENHANCES ACTIVITY OF ENZALUTAMIDE-RESISTANT PROSTATE CANCER', 'publication_year': 2014, 'publication_date': '2014-04-01', 'ids': {'openalex': 'https://openalex.org/W2059892851', 'doi': 'https://doi.org/10.1016/j.juro.2014.02.285', 'mag': '2059892851'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.juro.2014.02.285', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5071744718', 'display_name': 'Yoshiaki Yamamoto', 'orcid': 'https://orcid.org/0000-0002-8452-448X'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Yoshiaki Yamamoto', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045476512', 'display_name': 'Hiroaki Matsumoto', 'orcid': 'https://orcid.org/0000-0003-0568-1258'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Hiroaki Matsumoto', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034814953', 'display_name': 'Hidetoshi Kuruma', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Hidetoshi Kuruma', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038938817', 'display_name': 'Eliana Beraldi', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Eliana Beraldi', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101996417', 'display_name': 'Tianyuan Zhou', 'orcid': 'https://orcid.org/0000-0002-5496-4839'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Tianyuan Zhou', 'raw_affiliation_strings': ['Carlsbad, CA'], 'affiliations': [{'raw_affiliation_string': 'Carlsbad, CA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100395858', 'display_name': 'Youngsoo Kim', 'orcid': 'https://orcid.org/0000-0001-8289-0331'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Youngsoo Kim', 'raw_affiliation_strings': ['Carlsbad, CA'], 'affiliations': [{'raw_affiliation_string': 'Carlsbad, CA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044334898', 'display_name': 'Brett P. Monia', 'orcid': 'https://orcid.org/0000-0002-7473-1012'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Brett P. Monia', 'raw_affiliation_strings': ['Carlsbad, CA'], 'affiliations': [{'raw_affiliation_string': 'Carlsbad, CA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103250386', 'display_name': 'A. Robert MacLeod', 'orcid': 'https://orcid.org/0000-0002-8092-1840'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'A. Robert MacLeod', 'raw_affiliation_strings': ['Carlsbad, CA'], 'affiliations': [{'raw_affiliation_string': 'Carlsbad, CA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034110828', 'display_name': 'Ladan Fazli', 'orcid': 'https://orcid.org/0000-0001-6488-4245'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Ladan Fazli', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081653545', 'display_name': 'Amina Zoubeidi', 'orcid': 'https://orcid.org/0000-0002-0498-142X'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Amina Zoubeidi', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5062125605', 'display_name': 'Martin Gleave', 'orcid': 'https://orcid.org/0000-0003-4235-0167'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Martin Gleave', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': '191', 'issue': '4S', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12465', 'display_name': 'Lipid Metabolism in Cancer Pathogenesis', 'score': 0.9938, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12465', 'display_name': 'Lipid Metabolism in Cancer Pathogenesis', 'score': 0.9938, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T14364', 'display_name': 'Role of Clusterin in Cancer and Disease', 'score': 0.9895, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10543', 'display_name': 'Advancements in Prostate Cancer Research', 'score': 0.9885, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9390217}, {'id': 'https://openalex.org/keywords/clusterin', 'display_name': 'Clusterin', 'score': 0.8091354}, {'id': 'https://openalex.org/keywords/androgen-receptor', 'display_name': 'Androgen Receptor', 'score': 0.556028}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9390217}, {'id': 'https://openalex.org/C2779476363', 'wikidata': 'https://www.wikidata.org/wiki/Q14864935', 'display_name': 'Clusterin', 'level': 3, 'score': 0.8091354}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.7496745}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.71612203}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6022471}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.57375795}, {'id': 'https://openalex.org/C173396325', 'wikidata': 'https://www.wikidata.org/wiki/Q1501275', 'display_name': 'Gene knockdown', 'level': 3, 'score': 0.5668029}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.5553172}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.39565742}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3730058}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.23866421}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.17998067}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.juro.2014.02.285', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.69}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362621793', 'https://openalex.org/W4362621709', 'https://openalex.org/W4362609326', 'https://openalex.org/W4362609250', 'https://openalex.org/W4362495275', 'https://openalex.org/W4362495086', 'https://openalex.org/W2991319487', 'https://openalex.org/W2767048879', 'https://openalex.org/W2737056430', 'https://openalex.org/W2561061456'], 'abstract_inverted_index': {'You': [0], 'have': [1], 'accessJournal': [2], 'of': [3, 173, 237, 248, 274, 298, 346, 399], 'UrologyProstate': [4], 'Cancer:': [5], 'Basic': [6], 'Research': [7], 'I1': [8], 'Apr': [9], '2014MP24-04': [10], 'CO-TARGETING': [11], 'CLUSTERIN': [12], 'AND': [13, 19, 170], 'THE': [14], 'ANDROGEN': [15], 'RECEPTOR': [16], 'WITH': [17], 'OGX-011': [18, 232, 254, 278, 382], 'AN': [20], 'AR': [21, 205, 234, 301, 349, 403, 416], 'ANTISENSE': [22], 'SYNERGISTICALLY': [23], 'ENHANCES': [24], 'ACTIVITY': [25], 'OF': [26], 'ENZALUTAMIDE-RESISTANT': [27], 'PROSTATE': [28], 'CANCER': [29], 'Yoshiaki': [30, 55, 435], 'Yamamoto,': [31], 'Hiroaki': [32, 64, 442], 'Matsumoto,': [33], 'Hidetoshi': [34, 73, 449], 'Kuruma,': [35], 'Eliana': [36, 82, 456], 'Beraldi,': [37], 'Tianyuan': [38, 91, 463], 'Zhou,': [39], 'Youngsoo': [40, 100, 470], 'Kim,': [41], 'Brett': [42, 109, 477], 'P.': [43, 110, 112, 478], 'Monia,': [44], 'A.': [45, 120, 485], 'Robert': [46, 121, 123, 486], 'MacLeod,': [47], 'Ladan': [48, 131, 493], 'Fazli,': [49], 'Amina': [50, 140, 500], 'Zoubeidi,': [51], 'and': [52, 149, 208, 214, 239, 253, 261, 268, 277, 300, 326, 332, 340, 348, 362], 'Martin': [53, 150, 507], 'Gleave': [54, 152, 508], 'YamamotoYoshiaki': [56], 'Yamamoto': [57, 436], 'More': [58, 67, 76, 85, 94, 103, 114, 125, 134, 143, 153, 437, 444, 451, 458, 465, 472, 480, 488, 495, 502, 509], 'articles': [59, 68, 77, 86, 95, 104, 115, 126, 135, 144, 154, 438, 445, 452, 459, 466, 473, 481, 489, 496, 503, 510], 'by': [60, 69, 78, 87, 96, 105, 116, 127, 136, 145, 155, 204, 320, 439, 446, 453, 460, 467, 474, 482, 490, 497, 504, 511], 'this': [61, 70, 79, 88, 97, 106, 117, 128, 137, 146, 156, 227, 440, 447, 454, 461, 468, 475, 483, 491, 498, 505, 512], 'author': [62, 71, 80, 89, 98, 107, 118, 129, 138, 147, 157, 441, 448, 455, 462, 469, 476, 484, 492, 499, 506, 513], ',': [63, 72, 81, 90, 99, 108, 119, 130, 139, 148], 'MatsumotoHiroaki': [65], 'Matsumoto': [66, 443], 'KurumaHidetoshi': [74], 'Kuruma': [75, 450], 'BeraldiEliana': [83], 'Beraldi': [84, 457], 'ZhouTianyuan': [92], 'Zhou': [93, 464], 'KimYoungsoo': [101], 'Kim': [102, 471], 'MoniaBrett': [111], 'Monia': [113, 479], 'MacLeodA.': [122], 'MacLeod': [124, 487], 'FazliLadan': [132], 'Fazli': [133, 494], 'ZoubeidiAmina': [141], 'Zoubeidi': [142, 501], 'GleaveMartin': [151], 'View': [158], 'All': [159, 515], 'Author': [160], 'Informationhttps://doi.org/10.1016/j.juro.2014.02.285AboutPDF': [161], 'ToolsAdd': [162], 'to': [163, 303, 314, 357, 392], 'favoritesDownload': [164], 'CitationsTrack': [165], 'CitationsPermissionsReprints': [166], 'ShareFacebookTwitterLinked': [167], 'InEmail': [168], 'INTRODUCTION': [169], 'OBJECTIVES': [171], 'Suppression': [172, 398], 'androgen': [174], 'receptor': [175], '(AR)': [176], 'signaling': [177], 'with': [178, 369, 376, 402], 'potent': [179], 'inhibitors': [180], 'like': [181], 'Enzalutamide/MDV3100': [182], '(ENZ)': [183], 'remains': [184], 'a': [185, 414], 'therapeutic': [186], 'goal': [187], 'for': [188], 'castration': [189], 'resistant': [190], 'prostate': [191], 'cancer': [192], '(CRPC);': [193], 'however,': [194], 'ENZ-resistant': [195], '(ENZ-R)': [196], 'CRPC': [197, 304], 'frequently': [198], 'occurs.': [199], 'Clusterin': [200], '(CLU)': [201], 'is': [202], 'induced': [203, 316, 330], 'pathway': [206], 'inhibition': [207, 324], 'its': [209], 'overexpression': [210], 'confers': [211], 'treatment': [212], 'resistance': [213, 313], 'the': [215], 'CLU': [216, 256, 299, 311, 336, 347, 400], 'inhibitor,': [217], 'OGX-011,': [218], 'potentiates': [219], 'anticancer': [220], 'therapies': [221], 'in': [222, 243, 286, 335, 338, 419], 'many': [223], 'preclinical': [224], 'models.': [225], 'In': [226, 379], 'study,': [228], 'we': [229], 'tested': [230], 'whether': [231], 'sensitized': [233], 'knockdown': [235, 404], 'activity': [236], 'AR-ASO': [238, 252, 276, 315, 329, 384], 'delayed': [240, 386], 'ENZ-R': [241, 262, 280, 292, 341, 352, 387, 406, 420], 'progression': [242, 282, 390], 'LNCaP': [244, 263, 281, 305, 308, 342, 388, 407], 'model.': [245], 'METHODS': [246], 'Effects': [247, 273], 'single': [249], 'vs.': [250], 'combination': [251, 275], 'or': [255], 'siRNA': [257], 'regimens': [258], 'on': [259, 279], 'parental': [260, 339], 'cell': [264, 306, 322, 353, 408], 'growth': [265, 323, 354], 'rates,': [266], 'protein,': [267], 'gene': [269], 'expression': [270], 'were': [271, 284], 'analyzed.': [272], 'rates': [283, 325, 355], 'assessed': [285], 'castrated': [287], 'male': [288], 'athymic': [289], 'mice.': [290], 'RESULTS': [291], 'LNCaP-derived': [293], 'sub-lines': [294], 'expressed': [295], 'high': [296], 'levels': [297, 337], 'compared': [302, 356, 391], 'lines.': [307], 'cells': [309], 'overexpressing': [310], 'acquire': [312], 'apoptosis': [317, 327, 360], 'as': [318, 413], 'shown': [319], 'decreased': [321], 'induction.': [328], 'time-': [331], 'dose-dependent': [333], 'increases': [334], 'cells.': [343], 'Co-targeted': [344], 'suppression': [345], 'synergistically': [350], 'inhibited': [351, 405], 'monotherapy.': [358], 'Increased': [359], '(PARP': [361], 'caspase-3': [363], 'cleavage,': [364], 'sub': [365], 'G0/G1': [366], 'fraction)': [367], 'together': [368], 'reduced': [370], 'AKT': [371], 'phosphorylation': [372], 'was': [373], 'most': [374], 'enhanced': [375], 'combined': [377, 381, 401], 'therapy.': [378], 'vivo,': [380], '+': [383, 395], 'significantly': [385], 'tumor': [389], 'scramble': [393], 'ASO': [394], 'AR-ASO.': [396], 'CONCLUSIONS': [397], 'growth,': [409], 'providing': [410], 'pre-clinical': [411], 'proof-of-principle': [412], 'promising': [415], 'co-targeting': [417], 'approach': [418], 'CRPC.': [421], '©': [422], '2014FiguresReferencesRelatedDetails': [423], 'Volume': [424], '191Issue': [425], '4SApril': [426], '2014Page:': [427], 'e260-e261': [428], 'Advertisement': [429, 516, 517], 'Copyright': [430], '&': [431], 'Permissions©': [432], '2014MetricsAuthor': [433], 'Information': [434], 'Expand': [514], 'PDF': [518], 'downloadLoading': [519], '...': [520]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2059892851', 'counts_by_year': [], 'updated_date': '2024-09-15T22:24:55.394315', 'created_date': '2016-06-24'}